Omnicell, Inc. (NASDAQ:OMCL) Receives Consensus Recommendation of “Hold” from Analysts

Omnicell, Inc. (NASDAQ:OMCL) has received a consensus recommendation of “Hold” from the six ratings firms that are covering the firm, MarketBeat.com reports. Four analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 1 year price target among analysts that have covered the stock in the last year is $52.00.

Several research analysts have weighed in on the company. StockNews.com downgraded Omnicell from a “buy” rating to a “hold” rating in a report on Tuesday, December 10th. Wells Fargo & Company increased their target price on Omnicell from $30.00 to $41.00 and gave the stock an “equal weight” rating in a research report on Monday, October 14th. Barclays raised their price target on Omnicell from $39.00 to $58.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 31st. Bank of America reiterated a “neutral” rating and set a $57.00 price objective (up from $44.00) on shares of Omnicell in a report on Thursday, October 31st. Finally, Craig Hallum boosted their target price on shares of Omnicell from $45.00 to $64.00 and gave the company a “buy” rating in a report on Thursday, October 31st.

Omnicell Price Performance

NASDAQ:OMCL opened at $44.06 on Friday. The firm has a market cap of $2.04 billion, a PE ratio of -112.97, a P/E/G ratio of 34.96 and a beta of 0.77. The firm has a 50 day simple moving average of $45.73 and a 200-day simple moving average of $39.98. Omnicell has a 1-year low of $25.12 and a 1-year high of $55.74.

Insider Transactions at Omnicell

In related news, Director Mark W. Parrish sold 12,000 shares of Omnicell stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $47.30, for a total transaction of $567,600.00. Following the transaction, the director now owns 58,427 shares in the company, valued at approximately $2,763,597.10. The trade was a 17.04 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 2.64% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the stock. Pacer Advisors Inc. boosted its position in shares of Omnicell by 32.6% in the second quarter. Pacer Advisors Inc. now owns 2,070,434 shares of the company’s stock worth $56,047,000 after buying an additional 508,789 shares during the period. Dimensional Fund Advisors LP boosted its holdings in Omnicell by 0.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,180,503 shares of the company’s stock worth $31,955,000 after acquiring an additional 3,570 shares during the period. Victory Capital Management Inc. grew its position in Omnicell by 11,982.3% in the third quarter. Victory Capital Management Inc. now owns 1,148,426 shares of the company’s stock valued at $50,071,000 after acquiring an additional 1,138,921 shares in the last quarter. ArrowMark Colorado Holdings LLC raised its stake in shares of Omnicell by 27.1% during the third quarter. ArrowMark Colorado Holdings LLC now owns 1,140,873 shares of the company’s stock valued at $49,742,000 after purchasing an additional 243,353 shares during the period. Finally, Geode Capital Management LLC boosted its stake in shares of Omnicell by 0.3% in the third quarter. Geode Capital Management LLC now owns 1,104,745 shares of the company’s stock valued at $48,176,000 after purchasing an additional 2,877 shares during the period. 97.70% of the stock is owned by hedge funds and other institutional investors.

Omnicell Company Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.